Comparison of CNI-based Regimen Versus CNI-free Regimen in Kidney Transplant Recipients.

Stopped The trial was terminated early due to slow enrollment. It was determined that the planned sample size of 300 could not be achieved.

Conditions

• Renal Transplantation

Interventions

• DRUG: Everolimus
• DRUG: Cyclosporin A (CsA)
• DRUG: Tacrolimus
• DRUG: Enteric Coated - Mycophenolate Sodium (EC-MPS)
• DRUG: Corticosteroids

Sponsor

Novartis Pharmaceuticals